prodigiosin

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Nameprodigiosin
Drug Alias NameN/A
ClassificationNatural product/ExtractSmall molecules
Mechanisms of ActionBaculoviral IAP repeat-containing protein 5 inhibitors
TargetsBaculoviral IAP repeat-containing protein 5
Therapy Area/IndicationsPancreatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaPending
Originator CompaniesAida Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAida Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsPancreatic Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A